We're building a better ClinicalTrials.gov. Check it out and tell us what you think!

Key Record Dates

ClinicalTrials.gov Identifier: NCT04849364
Brief Title: Circulating Tumor DNA Enriched, Genomically Directed Post-neoadjuvant Trial for Patients With Residual Triple Negative Breast Cancer (PERSEVERE)

First Submitted : April 13, 2021
First Submitted that Met QC Criteria : April 13, 2021
First Posted : April 19, 2021

Last Update Submitted that Met QC Criteria : January 12, 2023
Last Update Posted : January 13, 2023